Not applicableUnknownNCT01486524
What this trial is testing
Pharmacogenomic Biomarker Study for Recombinant Human Activated Protein C Treatment in Severe Sepsis
Who this might be right for
Severe SepsisSeptic Shock
Sirius Genomics Inc. 3,000
Showing 6 of 6 results